#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Huntington's disease Anal cancer Hypersomnia Alternating hemiplegia of childhood Marginal zone lymphoma recurrent Undifferentiated sarcoma Progressive multifocal leukoencephalopathy Albright's disease Bladder cancer Cutaneous T-cell lymphoma recurrent Andersen-Tawil syndrome Cystic fibrosis Leukocyte adhesion deficiency Central nervous system neoplasm Optic glioma More trials…

    Learn about Rare Diseases

    Osteosarcoma – Trials in Disease Nephroblastoma – Diagnostics Von Willebrand’s disease – Trials in Disease Haemophilia A without inhibitors – Life with Disease Retinitis pigmentosa – Diagnostics Bronchiolitis obliterans syndrome – Trials in Disease Mucopolysaccharidosis II Netherton’s syndrome – Basic Information Acute respiratory distress syndrome – Diagnostics Isodicentric chromosome 15 syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [14C] DC-806 Napabucasin Sodium Oxybate Ranibizumab Goserelin Acetate Cat Epithelia Ly3537982 Betamethasone Sodium Phosphate Perflutren Ucp4 Acenocoumarol Atuliflapon SKB410 Aspergillus Fumigatus Bnt314 Elamipretide Trihydrochloride Ovolecithin Baloxavir Marboxil CILOSTAZOL Eribulin Mesylate More therapies…

    Learn about Your Condition

    Lung transplant rejection Anal squamous cell carcinoma Supranuclear palsy Dizziness Von Hippel-Lindau disease Diabetic gastroparesis Tendon disorder Neurotrophic keratopathy Ocular lymphoma Hip fracture Hodgkin's disease refractory Primary hyperthyroidism Hepatic cancer Carcinoid tumour pulmonary Kearns-Sayre syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    • Pembrolizumab
    The Netherlands

  • Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Nemolizumab
    Austria Belgium Denmark France Germany Hungary +5

  • Study on the Effects of Sonelokimab for Patients with Moderate-to-Severe Palmoplantar Pustulosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Investigated Drugs:
    • Sonelokimab
    Germany

  • Study of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris

    Not recruiting

    3 1
    Investigated Diseases:
    • Acne
    Investigated Drugs:
    • (S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
    Italy Poland Spain

  • Study on the Effectiveness and Safety of Danicopan for Adults with Chronic Spontaneous Urticaria Resistant to H1-Antihistamines

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Danicopan
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    • Neisseria Meningitidis Group W-135 Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    Germany

  • Long-Term Safety Study of Dupilumab for Children and Teens with Atopic Dermatitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Dupilumab
    Czechia Germany Poland
Previous Page
1 … 43 44 45 46 47 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!